Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -58.90%53.37M | ---- | 41.49%129.85M | ---- | 113.38%91.77M | --47.97M | 105.11%43.01M | -40.08%20.97M | -56.31%34.99M |
| Profit adjustment | ||||||||||
| Impairment and provisions: | ---- | 14.79%16.51M | ---- | 22.29%14.39M | ---- | 1.90%11.76M | --5.4M | 132.09%11.54M | -28.11%4.97M | -26.95%6.92M |
| -Impairmen of inventory (reversal) | ---- | 34.77%13.29M | ---- | 43.17%9.86M | ---- | -10.27%6.89M | --3.5M | 166.83%7.67M | -44.88%2.88M | 79.87%5.22M |
| -Other impairments and provisions | ---- | -28.72%3.23M | ---- | -7.20%4.53M | ---- | 26.02%4.88M | --1.9M | 84.46%3.87M | 23.34%2.1M | -74.11%1.7M |
| Revaluation surplus: | ---- | 100.03%24K | ---- | -92.43%-94.77M | ---- | -1,283.59%-49.25M | ---35.16M | -39.97%4.16M | -80.69%6.93M | --35.91M |
| -Other fair value changes | ---- | 100.03%24K | ---- | -92.43%-94.77M | ---- | -1,283.59%-49.25M | ---35.16M | -39.97%4.16M | -80.69%6.93M | --35.91M |
| Asset sale loss (gain): | ---- | 39.18%5.22M | ---- | 81.81%3.75M | ---- | -26.93%2.06M | --484K | 204.42%2.82M | 151.22%927K | 119.64%369K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 39.18%5.22M | ---- | 81.81%3.75M | ---- | -26.93%2.06M | --484K | 204.42%2.82M | 151.22%927K | 119.64%369K |
| Depreciation and amortization: | ---- | 14.00%143.77M | ---- | 12.72%126.12M | ---- | -4.05%111.88M | --58.71M | 19.78%116.61M | 76.48%97.35M | 181.29%55.16M |
| -Depreciation | ---- | 16.05%132.7M | ---- | 16.37%114.35M | ---- | -4.21%98.27M | --51.57M | 17.92%102.58M | 80.30%87M | 190.02%48.25M |
| -Amortization of intangible assets | ---- | -5.91%11.07M | ---- | -13.57%11.77M | ---- | -2.94%13.61M | --7.14M | 35.43%14.03M | 49.82%10.36M | 132.45%6.91M |
| Financial expense | ---- | -1.69%160.39M | ---- | 13.30%163.14M | ---- | 20.16%143.99M | --73.68M | 7.93%119.83M | 7.79%111.02M | 60.01%103M |
| Special items | ---- | 3.89%-1.58M | ---- | -68.96%-1.64M | ---- | 51.54%-973K | ---496K | -8.60%-2.01M | 72.90%-1.85M | -746.02%-6.82M |
| Operating profit before the change of operating capital | ---- | 10.82%377.7M | ---- | 9.50%340.82M | ---- | 5.16%311.25M | --150.59M | 23.15%295.97M | 4.70%240.33M | 31.32%229.53M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -162.61%-122.13M | ---- | 20.69%-46.51M | ---- | -451.00%-58.64M | --3.05M | -125.65%-10.64M | -23.50%41.48M | 141.46%54.23M |
| Accounts receivable (increase)decrease | ---- | -23.41%-210.05M | ---- | 18.05%-170.2M | ---- | 27.84%-207.69M | --35K | -387.60%-287.83M | 142.09%100.08M | -12.11%-237.78M |
| Accounts payable increase (decrease) | ---- | -236.98%-72.07M | ---- | 36.71%52.61M | ---- | 38.66%38.49M | ---468K | 2,867.20%27.76M | -104.02%-1M | -29.60%24.96M |
| Special items for working capital changes | ---- | 605.55%5.65M | ---- | -339.91%-1.12M | ---- | -90.03%466K | --2M | 148.32%4.68M | ---9.68M | ---- |
| Cash from business operations | -28.56%69.31M | -111.90%-20.89M | -5.83%97.02M | 109.39%175.61M | -33.62%103.02M | 180.22%83.87M | --155.21M | -91.94%29.93M | 423.27%371.21M | 153.48%70.94M |
| Other taxs | -55.93%-12.41M | 30.91%-7.96M | 30.96%-7.96M | 20.03%-11.52M | 19.92%-11.53M | -60.82%-14.41M | ---14.4M | 43.08%-8.96M | 35.11%-15.74M | -7.21%-24.25M |
| Interest paid - operating | -7.79%-87.75M | 2.19%-159.22M | 3.37%-81.41M | -13.46%-162.78M | -26.32%-84.25M | -45.82%-143.46M | ---66.7M | 21.67%-98.38M | -38.81%-125.59M | -48.64%-90.48M |
| Net cash from operations | -503.39%-30.85M | -14,390.96%-188.07M | 5.58%7.65M | 101.78%1.32M | -90.23%7.24M | 4.40%-74M | --74.12M | -133.67%-77.41M | 624.93%229.88M | 79.74%-43.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -25.21%181K | -46.99%343K | -29.65%242K | 183.77%647K | 230.77%344K | -28.75%228K | --104K | -58.06%320K | -79.05%763K | 241.33%3.64M |
| Sale of fixed assets | 27.78%19.19M | -3.39%39.17M | 9.89%15.02M | 35.95%40.55M | -35.18%13.67M | 21.16%29.82M | --21.08M | 206.81%24.62M | 364.83%8.02M | -23.63%1.73M |
| Purchase of fixed assets | 1.84%-135.88M | 11.71%-132.72M | 0.54%-138.43M | -9.00%-150.33M | -733.18%-139.18M | -202.29%-137.91M | ---16.7M | 72.67%-45.62M | 47.96%-166.91M | -1,000.69%-320.73M |
| Purchase of intangible assets | -3.58%-5M | 77.87%-11.99M | 1.97%-4.83M | -380.72%-54.19M | 3.20%-4.93M | 1.85%-11.27M | ---5.09M | 12.32%-11.48M | 25.84%-13.1M | -107.13%-17.66M |
| Recovery of cash from investments | ---- | --20M | --7M | ---- | ---- | ---- | ---- | --2M | ---- | ---- |
| Cash on investment | ---- | ---48.53M | ---22.5M | ---- | ---- | ---- | ---- | ---28M | ---- | ---- |
| Net cash from investment operations | 15.32%-121.51M | 18.12%-133.73M | -10.31%-143.5M | -37.09%-163.32M | -21,332.13%-130.09M | -104.79%-119.13M | ---607K | 66.02%-58.17M | 48.59%-171.22M | -869.83%-333.02M |
| Net cash before financing | -12.15%-152.36M | -98.63%-321.79M | -10.59%-135.85M | 16.12%-162M | -267.12%-122.85M | -42.45%-193.13M | --73.51M | -331.12%-135.58M | 115.57%58.66M | -50.44%-376.81M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 65.50%1.19B | 40.16%1.84B | 7.62%721.22M | -1.67%1.32B | 56.25%670.13M | 14.49%1.34B | --428.89M | 82.97%1.17B | -40.04%638.87M | 26.58%1.07B |
| Refund | -75.80%-1.05B | -22.85%-1.43B | -13.95%-597.21M | -15.99%-1.16B | -0.45%-524.12M | -4.09%-1B | ---521.76M | -24.79%-963.75M | 4.43%-772.33M | -59.20%-808.14M |
| Issuing shares | ---- | ---- | ---- | --91.24M | ---- | ---- | ---- | --20M | ---- | 266.67%110M |
| Dividends paid - financing | ---- | ---3.37M | ---- | ---- | ---- | ---- | ---- | 53.19%-6.32M | 43.47%-13.51M | 29.93%-23.9M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 26.26%214.07M | 888.62%169.55M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | -60.80%-1.53M | ---- | -206.75%-954K | 49.08%-2.4M | ---311K | -54.36%-4.71M | ---3.05M | ---- |
| Other items of the financing business | 299.17%5.97M | -22.16%-9.38M | 52.07%-3M | 28.07%-7.68M | -284.57%-6.26M | -262.22%-10.67M | --3.39M | 98.64%-2.95M | -31.77%-217.25M | -862.88%-164.87M |
| Net cash from financing operations | 25.14%145.42M | 72.63%394.55M | -14.07%116.21M | -27.41%228.55M | 244.80%135.24M | 55.03%314.83M | ---93.4M | 224.58%203.07M | -147.96%-163.01M | 5.59%339.86M |
| Effect of rate | -55.47%114K | -3.54%109K | -54.45%256K | 927.27%113K | 140.17%562K | --11K | --234K | ---- | -5,633.96%-2.93M | --53K |
| Other items affecting net cash | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | --1K | ---- | ---3.77M |
| Net Cash | 64.67%-6.94M | 9.34%72.76M | -258.54%-19.65M | -45.32%66.54M | 162.30%12.39M | 80.31%121.69M | ---19.89M | 164.68%67.49M | -156.24%-104.35M | -157.03%-40.72M |
| Begining period cash | 27.22%340.6M | 33.15%267.73M | 33.15%267.73M | 153.33%201.08M | 153.33%201.08M | 568.12%79.37M | --79.37M | -90.03%11.88M | -25.45%119.16M | 80.75%159.83M |
| Cash at the end | 34.40%333.77M | 27.22%340.6M | 16.03%248.34M | 33.15%267.73M | 258.40%214.03M | 153.33%201.08M | --59.72M | 568.12%79.37M | -90.03%11.88M | -25.45%119.16M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | PricewaterhouseCoopers | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.